MKI The Medipattern Corp.

Attention: Business/Financial Editors

The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a pioneer in the
development of medical imaging software solutions that help medical
practitioners to better understand lesions and critical anatomy, announced today
that the Company's new Visualize:Vascular(TM) product has been installed and is
in use with customers who occupy all market sectors: vascular surgery,
cardiology and radiology. Vascular surgery practices include: Eastern Vascular
Diagnostics, Bronx, NY and Northeast Philadelphia Vascular Surgeons,
Philadelphia, PA. Cardiology practices include Farmingdale Heart, Farmingdale,
NY. Radiology practices include: Milburn Medical Imaging, Maplewood, NJ,
University Diagnostic Medical Imaging, Bronx, NY and XXI Century Radiology
Imaging, Brooklyn, NY. 


Medipattern launched Visualize:Vascular(TM) into a variety of practices with
various types of equipment, in various states in the United States and into all
of the major market sectors. The intention was to better understand the market
dynamics in each segment and the Company's product capabilities in daily use in
these sectors. As with all new products, Medipattern identified some
improvements to workflow in the product as it moved towards a national roll-out.
As previously reported, Medipattern's ability to generate revenue from the
product to date has been impacted by workflow concerns. The Company has now
taken action on some immediate workflow changes and has put a plan in place for
adding improvement as the product is rolled out. 


"Visualize:Vascular(TM) post processes images to perform 3D rendering of the
carotid artery. 3D rendering is a standard procedure defined in the current
Common Procedural Terminology (CPT) used in the United States and as such has
had a CPT code assigned to the procedure for many years," commented Medipattern
CEO, Jeff Collins. "Reimbursement using this code has been validated in all
three of our launch phase states across all market segments, another key
component in our ability to generate revenue from the product. We have added
staff and resources to the commercial side of our company to support the
continued roll out. We look forward to expanding the product launch on a U.S.
national basis during calendar 2012."


Upcoming Events



45th Annual Mid-Winter Leadership                                           
 Conference MHA                              Jan 27, 2012     Framingham, MA
                                                                            
Annual Hospital - Physician                                                 
 Leadership Conference MHA                   Mar 16, 2012        Waltham, MA
                                                                            
Annual Meeting - MHA                     June 6 - 7, 2012       Brewster, MA
                                                                            
SVU/SVS Annual Conference                June 7 - 9, 2012      Baltimore, MD



About the Medipattern Corporation:

Medipattern(R) is a pioneer in the development of imaging software solutions
that help medical practitioners to better understand lesions and critical
anatomy. Medipattern uses its Cadenza(TM) technology to process images, finding
the salient region of interest and presenting them in 2D and 3D formats that
enhance the reader's perception. For more information, please visit the
Company's website: www.medipattern.com.


Medipattern(R) is a registered mark of The Medipattern Corporation.
Visualize:Vascular(TM) is a trademark of the Medipattern Corporation.


Forward-looking statements

This document contains forward-looking statements relating to Medipattern's
performance, operations, or business environment. These statements are based on
what we believe are reasonable assumptions given currently available information
and our understanding of Medipattern's current activities. We have tried,
whenever possible, to identify these forward-looking statements using words such
as "anticipates," "believes," "estimates," "expects," "plans," "intends,"
"potential", and similar expressions. Forward-looking statements are not
guarantees of future performance and involve risks and uncertainties that are
difficult to predict or control. A number of factors could cause actual outcomes
and results to differ materially from those expressed in forward-looking
statements. These factors include but are not limited to those set forth in the
Company's corporate filings, (posted at www.sedar.com). In addition, these
forward-looking statements relate to the date on which they are made. The
Company disclaims any intention or obligation to update or revise any
forward-looking statements for any reason. Readers should not rely on
forward-looking statements.

The Medipattern Corp. (TSXV:MKI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

The Medipattern Corp. (TSXV:MKI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024